A

argenx

Develops antibody-based therapies for autoimmune diseases

Head of Commercial Analytics & Insights

Business IntelligenceConfirmed live in the last 24 hours
Full-timeRemote in USARemote

About the Job

Requirements

  • Influence cross-functional teams, including internal and external stakeholders and scientific and commercial teams.
  • Manage commercial vendors and service providers to deliver actionable analytics, insights, and business support.
  • Translate US Commercialization priorities into practical data, AI, and self-serve analytics requirements and adoption plans.
  • Understand regulatory and legal requirements for pharmaceutical commercial operations.
  • Hold a BA or BS; an MBA is preferred.
  • Have at least 10 years of experience in commercial functions within the biopharmaceutical industry, including 5–7 years in commercial analytics, business intelligence, performance analytics, forecasting, or AI-enabled decision support.
  • Understand commercial data sources, reporting, segmentation, forecasting, performance analytics, advanced analytics methodologies, and applications of AI in business decision-making.
  • Define business issues and recommendations using strong analytical skills.
  • Be familiar with leading pharmaceutical industry commercial vendors.

Responsibilities

  • Drive commercial decision-making, performance management, and business planning across US Commercialization using data management, AI enablement, and self-serve analytics capabilities.
  • Inspire, coach, manage, and develop employees to achieve and grow as individuals and as a cohesive team.
  • Manage external vendor relationships to ensure high-quality, actionable deliverables that support US Commercialization priorities.
  • Establish a culture of objective, data-driven decision-making by embedding trusted data, scalable analytics, AI-enabled methods, and self-serve insight tools into commercial business routines.
  • Deliver integrated commercial, customer, patient, product, and performance insights that are actionable for teams and support commercial goals.
  • Translate US Commercialization business needs into high-value analytics, reporting, and AI use cases that support existing and future assets.
  • Analyze, synthesize, and interpret data across sources to generate timely reports, dashboards, and executive-ready recommendations for brand and leadership teams.
  • Support senior management preparation for investor calls and meetings, including earnings calls, JPM, and other external engagements, by providing timely data facts, insights, and executive-ready briefing materials.
  • Serve as a senior commercial analytics partner to business leaders, helping teams interpret data, apply AI-enabled insights, and make informed decisions across provider, patient, payor, and performance domains.
  • Ensure US Commercial teams can access, understand, and confidently use trusted data, analytics, and AI-enabled insights in brand, launch, performance, and pipeline planning processes.
  • Accelerate AI usage across US Commercialization by identifying decision points where AI-enabled analytics can improve planning, execution, and performance management, and championing adoption of scalable solutions.
  • Assess commercial strategies and tactics through performance measurement, ROI analytics, predictive insights, and recommendations that optimize existing and future resources.
  • Partner with Finance to manage the department budget, including vendor agreements and contracts.

Desired Qualifications

  • Start-up and launch experience.

About the Company

argenx

Develops antibody-based therapies for autoimmune diseases

Argenx develops and markets antibody-based therapies for severe autoimmune diseases, turning immunology research into medicines. Its lead drug, efgartigimod (VYVGART), and the subcutaneous VYVGART Hytrulo treat conditions like generalized myasthenia gravis and CIDP by modulating the immune system through FcRn pathways. The company differentiates itself with antibody engineering and a co-creation model with academic and industry partners, plus a pipeline targeting FcRn-, complement-, and other autoimmune pathways and a global development footprint. Its goal is to provide effective antibody medicines for autoimmune diseases and broaden global patient access.

Company size
1,001-5,000
Company stage
IPO
Headquarters
Amsterdam, Netherlands
Founded
2008

Recently Posted Jobs

Explore more opportunities at argenx

See more jobs